Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Golan resident convicted of spying for Iran after passing tank movement, missile-impact data - 2Lebanese Shi’a party Amal competing, coordinating with Hezbollah, experts tell ‘Post’
- 3Figure out How to Score Huge with Open Record Rewards
- 4Vote In favor of Your Favored Sort Of Bevarage
- 5A definitive Bike Standoff: Decision in favor of Your Number one Ride
- Rick Steves' Favorite Time To Visit Spain Has Lower Prices And Fewer Crowds
- Top 20 Wellbeing and Wellness Applications for a Sound Way of life
- Tech for Learning: Online Courses and Instructive Apparatuses
- 3D Printers for Specialists
- Deadly attack on kindergarten reported in Sudan
- 3 astronauts settle into their new life in orbit | On the International Space Station this week Dec. 1-5, 2025
- German journalists' union condemns attack on reporters in village
- 2 new malaria treatments announced as drug resistance grows
- Parents who delay baby's first vaccines also likely to skip measles shots
